Funds holding “LENZ Therapeutics Inc”
Which closed-end funds own a security? Searches the latest N-PORT snapshot of every active fund. Enter a ticker (issuer-level: matches the vendor-mapped ticker), a CUSIP or ISIN (security-level: one specific bond or share class), or part of a name.
3 positions across 3 funds. Weights are percent of net assets from each fund’s latest N-PORT; report dates differ by fund.
| Fund | Position | Identifier | Type | Weight | Value (USD) | Report date | Coverage |
|---|---|---|---|---|---|---|---|
| HQH abrdn Healthcare Investors Healthcare | LENZ Therapeutics Inc | 52635N103 | EC | 0.44% | $5.9M | Jun 30, 2026 | full (154 positions) |
| HQL abrdn Life Sciences Investors Healthcare | LENZ Therapeutics Inc | 52635N103 | EC | 0.41% | $2.8M | Jun 30, 2026 | full (145 positions) |
| GUG Guggenheim Active Allocation Fund U.S. Equity | LENZ THERAPEUTICS INC | 52635N103 | EC | 0.00% | $171 | May 29, 2026 | full (1,258 positions) |
Matching position names
Historical holdings reports are not a real-time portfolio. Security-level matching (CUSIP/ISIN) distinguishes a company’s bonds, common shares, preferreds and derivatives; issuer-level matching groups them by name or ticker and is labelled as such. See the overlap tool to compare two portfolios.